RAB35 and adenocarcinoma: The variable expression of RAB35 was also observed across a panel of human prostate cancer in a Tissue Microarray (TMA) with 12/56 (21.4%) adenocarcinoma displaying elevated levels of RAB35 (score ≥ 1.5), whereas only 2/32 (6%) of normal prostate tissues displayed RAB35 scores = 1.5 (Supplementary Figure 4D).